Review



apc conjugated anti cd163  (Elabscience Biotechnology)


Bioz Verified Symbol Elabscience Biotechnology is a verified supplier
Bioz Manufacturer Symbol Elabscience Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Elabscience Biotechnology apc conjugated anti cd163
    Apc Conjugated Anti Cd163, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+conjugated+anti+cd163/pmc13014926-101-24-26?v=Elabscience+Biotechnology
    Average 94 stars, based on 6 article reviews
    apc conjugated anti cd163 - by Bioz Stars, 2026-08
    94/100 stars

    Images



    Similar Products

    94
    Miltenyi Biotec m2 polarization phenotyping apc conjugated cd163
    M1 and M2 marker expression is not affected by incubation with sEVs derived from healthy donors or PrCa patients. Flow cytometric analysis of monocytes isolated from healthy volunteers. ( A ) Histogram representation of the mean fluorescent intensity (MFI) of M2 polarization markers <t>(CD163</t> and CD204, top panels) and M1 polarization markers (CD80 and HLA-DR, bottom panels) expressed by monocytes after incubation with PBS (−, green) or PrCa patient plasma-derived sEVs (orange) ( n = 13). The isotype control is depicted in red. ( B ) Statistical analysis of M2 marker <t>(CD163</t> and CD204, top panels) and M1 marker (CD80 and HLA-DR, bottom panels) expression in monocytes after incubation with PBS (−) or PrCa patient plasma-derived sEVs ( n = 13). ( C ) Histogram representation of the MFI of M2 (top panels) and M1 (bottom panels) markers expressed by monocytes after incubation with PBS (−, green), healthy donor (Healthy d.) plasma-derived sEVs (blue), or PrCa patient plasma-derived sEVs (orange) ( n = 3). The isotype control is depicted in red. ( D ) Statistical analysis of M2 (top panels) and M1 (bottom panels) marker levels in monocytes after incubation with PBS (−), healthy donor plasma-derived sEVs or PrCa patient plasma-derived sEVs ( n = 3). ( B, D ) The results are shown in scatter graphs. Paired t -test was used for paired two group comparison; ANOVA for repeated measures with Tukey’s multiple comparisons test was used for multiple groups comparisons with matched samples. SAS 9.4 and Prism 7 were used for data analysis. A.U.: Arbitrary Units.
    M2 Polarization Phenotyping Apc Conjugated Cd163, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+conjugated+anti+cd163/pmc10823877-152-21-26?v=Miltenyi+Biotec
    Average 94 stars, based on 1 article reviews
    m2 polarization phenotyping apc conjugated cd163 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    90
    Thermo Fisher apc-conjugated anti-human cd163 antibodies
    M1 and M2 marker expression is not affected by incubation with sEVs derived from healthy donors or PrCa patients. Flow cytometric analysis of monocytes isolated from healthy volunteers. ( A ) Histogram representation of the mean fluorescent intensity (MFI) of M2 polarization markers <t>(CD163</t> and CD204, top panels) and M1 polarization markers (CD80 and HLA-DR, bottom panels) expressed by monocytes after incubation with PBS (−, green) or PrCa patient plasma-derived sEVs (orange) ( n = 13). The isotype control is depicted in red. ( B ) Statistical analysis of M2 marker <t>(CD163</t> and CD204, top panels) and M1 marker (CD80 and HLA-DR, bottom panels) expression in monocytes after incubation with PBS (−) or PrCa patient plasma-derived sEVs ( n = 13). ( C ) Histogram representation of the MFI of M2 (top panels) and M1 (bottom panels) markers expressed by monocytes after incubation with PBS (−, green), healthy donor (Healthy d.) plasma-derived sEVs (blue), or PrCa patient plasma-derived sEVs (orange) ( n = 3). The isotype control is depicted in red. ( D ) Statistical analysis of M2 (top panels) and M1 (bottom panels) marker levels in monocytes after incubation with PBS (−), healthy donor plasma-derived sEVs or PrCa patient plasma-derived sEVs ( n = 3). ( B, D ) The results are shown in scatter graphs. Paired t -test was used for paired two group comparison; ANOVA for repeated measures with Tukey’s multiple comparisons test was used for multiple groups comparisons with matched samples. SAS 9.4 and Prism 7 were used for data analysis. A.U.: Arbitrary Units.
    Apc Conjugated Anti Human Cd163 Antibodies, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+conjugated+anti+cd163/pmc11727125-293-22-26?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    apc-conjugated anti-human cd163 antibodies - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology apc conjugated anti cd163
    M1 and M2 marker expression is not affected by incubation with sEVs derived from healthy donors or PrCa patients. Flow cytometric analysis of monocytes isolated from healthy volunteers. ( A ) Histogram representation of the mean fluorescent intensity (MFI) of M2 polarization markers <t>(CD163</t> and CD204, top panels) and M1 polarization markers (CD80 and HLA-DR, bottom panels) expressed by monocytes after incubation with PBS (−, green) or PrCa patient plasma-derived sEVs (orange) ( n = 13). The isotype control is depicted in red. ( B ) Statistical analysis of M2 marker <t>(CD163</t> and CD204, top panels) and M1 marker (CD80 and HLA-DR, bottom panels) expression in monocytes after incubation with PBS (−) or PrCa patient plasma-derived sEVs ( n = 13). ( C ) Histogram representation of the MFI of M2 (top panels) and M1 (bottom panels) markers expressed by monocytes after incubation with PBS (−, green), healthy donor (Healthy d.) plasma-derived sEVs (blue), or PrCa patient plasma-derived sEVs (orange) ( n = 3). The isotype control is depicted in red. ( D ) Statistical analysis of M2 (top panels) and M1 (bottom panels) marker levels in monocytes after incubation with PBS (−), healthy donor plasma-derived sEVs or PrCa patient plasma-derived sEVs ( n = 3). ( B, D ) The results are shown in scatter graphs. Paired t -test was used for paired two group comparison; ANOVA for repeated measures with Tukey’s multiple comparisons test was used for multiple groups comparisons with matched samples. SAS 9.4 and Prism 7 were used for data analysis. A.U.: Arbitrary Units.
    Apc Conjugated Anti Cd163, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+conjugated+anti+cd163/pmc13014926-101-24-26?v=Elabscience+Biotechnology
    Average 94 stars, based on 1 article reviews
    apc conjugated anti cd163 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    93
    R&D Systems apc conjugated anti cd163
    M1 and M2 marker expression is not affected by incubation with sEVs derived from healthy donors or PrCa patients. Flow cytometric analysis of monocytes isolated from healthy volunteers. ( A ) Histogram representation of the mean fluorescent intensity (MFI) of M2 polarization markers <t>(CD163</t> and CD204, top panels) and M1 polarization markers (CD80 and HLA-DR, bottom panels) expressed by monocytes after incubation with PBS (−, green) or PrCa patient plasma-derived sEVs (orange) ( n = 13). The isotype control is depicted in red. ( B ) Statistical analysis of M2 marker <t>(CD163</t> and CD204, top panels) and M1 marker (CD80 and HLA-DR, bottom panels) expression in monocytes after incubation with PBS (−) or PrCa patient plasma-derived sEVs ( n = 13). ( C ) Histogram representation of the MFI of M2 (top panels) and M1 (bottom panels) markers expressed by monocytes after incubation with PBS (−, green), healthy donor (Healthy d.) plasma-derived sEVs (blue), or PrCa patient plasma-derived sEVs (orange) ( n = 3). The isotype control is depicted in red. ( D ) Statistical analysis of M2 (top panels) and M1 (bottom panels) marker levels in monocytes after incubation with PBS (−), healthy donor plasma-derived sEVs or PrCa patient plasma-derived sEVs ( n = 3). ( B, D ) The results are shown in scatter graphs. Paired t -test was used for paired two group comparison; ANOVA for repeated measures with Tukey’s multiple comparisons test was used for multiple groups comparisons with matched samples. SAS 9.4 and Prism 7 were used for data analysis. A.U.: Arbitrary Units.
    Apc Conjugated Anti Cd163, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+conjugated+anti+cd163/10__1016_slash_j__vetmic__2025__110733-79-5-7?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    apc conjugated anti cd163 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    90
    Sony allophycocyanin (apc)-conjugated anti-cd163 monoclonal antibody
    M1 and M2 marker expression is not affected by incubation with sEVs derived from healthy donors or PrCa patients. Flow cytometric analysis of monocytes isolated from healthy volunteers. ( A ) Histogram representation of the mean fluorescent intensity (MFI) of M2 polarization markers <t>(CD163</t> and CD204, top panels) and M1 polarization markers (CD80 and HLA-DR, bottom panels) expressed by monocytes after incubation with PBS (−, green) or PrCa patient plasma-derived sEVs (orange) ( n = 13). The isotype control is depicted in red. ( B ) Statistical analysis of M2 marker <t>(CD163</t> and CD204, top panels) and M1 marker (CD80 and HLA-DR, bottom panels) expression in monocytes after incubation with PBS (−) or PrCa patient plasma-derived sEVs ( n = 13). ( C ) Histogram representation of the MFI of M2 (top panels) and M1 (bottom panels) markers expressed by monocytes after incubation with PBS (−, green), healthy donor (Healthy d.) plasma-derived sEVs (blue), or PrCa patient plasma-derived sEVs (orange) ( n = 3). The isotype control is depicted in red. ( D ) Statistical analysis of M2 (top panels) and M1 (bottom panels) marker levels in monocytes after incubation with PBS (−), healthy donor plasma-derived sEVs or PrCa patient plasma-derived sEVs ( n = 3). ( B, D ) The results are shown in scatter graphs. Paired t -test was used for paired two group comparison; ANOVA for repeated measures with Tukey’s multiple comparisons test was used for multiple groups comparisons with matched samples. SAS 9.4 and Prism 7 were used for data analysis. A.U.: Arbitrary Units.
    Allophycocyanin (Apc) Conjugated Anti Cd163 Monoclonal Antibody, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+conjugated+anti+cd163/pm40054049-103-25-30?v=Sony
    Average 90 stars, based on 1 article reviews
    allophycocyanin (apc)-conjugated anti-cd163 monoclonal antibody - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    93
    R&D Systems anti cd163
    M1 and M2 marker expression is not affected by incubation with sEVs derived from healthy donors or PrCa patients. Flow cytometric analysis of monocytes isolated from healthy volunteers. ( A ) Histogram representation of the mean fluorescent intensity (MFI) of M2 polarization markers <t>(CD163</t> and CD204, top panels) and M1 polarization markers (CD80 and HLA-DR, bottom panels) expressed by monocytes after incubation with PBS (−, green) or PrCa patient plasma-derived sEVs (orange) ( n = 13). The isotype control is depicted in red. ( B ) Statistical analysis of M2 marker <t>(CD163</t> and CD204, top panels) and M1 marker (CD80 and HLA-DR, bottom panels) expression in monocytes after incubation with PBS (−) or PrCa patient plasma-derived sEVs ( n = 13). ( C ) Histogram representation of the MFI of M2 (top panels) and M1 (bottom panels) markers expressed by monocytes after incubation with PBS (−, green), healthy donor (Healthy d.) plasma-derived sEVs (blue), or PrCa patient plasma-derived sEVs (orange) ( n = 3). The isotype control is depicted in red. ( D ) Statistical analysis of M2 (top panels) and M1 (bottom panels) marker levels in monocytes after incubation with PBS (−), healthy donor plasma-derived sEVs or PrCa patient plasma-derived sEVs ( n = 3). ( B, D ) The results are shown in scatter graphs. Paired t -test was used for paired two group comparison; ANOVA for repeated measures with Tukey’s multiple comparisons test was used for multiple groups comparisons with matched samples. SAS 9.4 and Prism 7 were used for data analysis. A.U.: Arbitrary Units.
    Anti Cd163, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+conjugated+anti+cd163/pm39172519-173-12-13?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    anti cd163 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    R&D Systems anti hucd163
    M1 and M2 marker expression is not affected by incubation with sEVs derived from healthy donors or PrCa patients. Flow cytometric analysis of monocytes isolated from healthy volunteers. ( A ) Histogram representation of the mean fluorescent intensity (MFI) of M2 polarization markers <t>(CD163</t> and CD204, top panels) and M1 polarization markers (CD80 and HLA-DR, bottom panels) expressed by monocytes after incubation with PBS (−, green) or PrCa patient plasma-derived sEVs (orange) ( n = 13). The isotype control is depicted in red. ( B ) Statistical analysis of M2 marker <t>(CD163</t> and CD204, top panels) and M1 marker (CD80 and HLA-DR, bottom panels) expression in monocytes after incubation with PBS (−) or PrCa patient plasma-derived sEVs ( n = 13). ( C ) Histogram representation of the MFI of M2 (top panels) and M1 (bottom panels) markers expressed by monocytes after incubation with PBS (−, green), healthy donor (Healthy d.) plasma-derived sEVs (blue), or PrCa patient plasma-derived sEVs (orange) ( n = 3). The isotype control is depicted in red. ( D ) Statistical analysis of M2 (top panels) and M1 (bottom panels) marker levels in monocytes after incubation with PBS (−), healthy donor plasma-derived sEVs or PrCa patient plasma-derived sEVs ( n = 3). ( B, D ) The results are shown in scatter graphs. Paired t -test was used for paired two group comparison; ANOVA for repeated measures with Tukey’s multiple comparisons test was used for multiple groups comparisons with matched samples. SAS 9.4 and Prism 7 were used for data analysis. A.U.: Arbitrary Units.
    Anti Hucd163, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+conjugated+anti+cd163/us11827715-1589-7-8?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    anti hucd163 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    90
    Sony allophycocyanin (apc)-conjugated anti-cd163 moab
    M1 and M2 marker expression is not affected by incubation with sEVs derived from healthy donors or PrCa patients. Flow cytometric analysis of monocytes isolated from healthy volunteers. ( A ) Histogram representation of the mean fluorescent intensity (MFI) of M2 polarization markers <t>(CD163</t> and CD204, top panels) and M1 polarization markers (CD80 and HLA-DR, bottom panels) expressed by monocytes after incubation with PBS (−, green) or PrCa patient plasma-derived sEVs (orange) ( n = 13). The isotype control is depicted in red. ( B ) Statistical analysis of M2 marker <t>(CD163</t> and CD204, top panels) and M1 marker (CD80 and HLA-DR, bottom panels) expression in monocytes after incubation with PBS (−) or PrCa patient plasma-derived sEVs ( n = 13). ( C ) Histogram representation of the MFI of M2 (top panels) and M1 (bottom panels) markers expressed by monocytes after incubation with PBS (−, green), healthy donor (Healthy d.) plasma-derived sEVs (blue), or PrCa patient plasma-derived sEVs (orange) ( n = 3). The isotype control is depicted in red. ( D ) Statistical analysis of M2 (top panels) and M1 (bottom panels) marker levels in monocytes after incubation with PBS (−), healthy donor plasma-derived sEVs or PrCa patient plasma-derived sEVs ( n = 3). ( B, D ) The results are shown in scatter graphs. Paired t -test was used for paired two group comparison; ANOVA for repeated measures with Tukey’s multiple comparisons test was used for multiple groups comparisons with matched samples. SAS 9.4 and Prism 7 were used for data analysis. A.U.: Arbitrary Units.
    Allophycocyanin (Apc) Conjugated Anti Cd163 Moab, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+conjugated+anti+cd163/pmc10605812-80-28-30?v=Sony
    Average 90 stars, based on 1 article reviews
    allophycocyanin (apc)-conjugated anti-cd163 moab - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    Image Search Results


    M1 and M2 marker expression is not affected by incubation with sEVs derived from healthy donors or PrCa patients. Flow cytometric analysis of monocytes isolated from healthy volunteers. ( A ) Histogram representation of the mean fluorescent intensity (MFI) of M2 polarization markers (CD163 and CD204, top panels) and M1 polarization markers (CD80 and HLA-DR, bottom panels) expressed by monocytes after incubation with PBS (−, green) or PrCa patient plasma-derived sEVs (orange) ( n = 13). The isotype control is depicted in red. ( B ) Statistical analysis of M2 marker (CD163 and CD204, top panels) and M1 marker (CD80 and HLA-DR, bottom panels) expression in monocytes after incubation with PBS (−) or PrCa patient plasma-derived sEVs ( n = 13). ( C ) Histogram representation of the MFI of M2 (top panels) and M1 (bottom panels) markers expressed by monocytes after incubation with PBS (−, green), healthy donor (Healthy d.) plasma-derived sEVs (blue), or PrCa patient plasma-derived sEVs (orange) ( n = 3). The isotype control is depicted in red. ( D ) Statistical analysis of M2 (top panels) and M1 (bottom panels) marker levels in monocytes after incubation with PBS (−), healthy donor plasma-derived sEVs or PrCa patient plasma-derived sEVs ( n = 3). ( B, D ) The results are shown in scatter graphs. Paired t -test was used for paired two group comparison; ANOVA for repeated measures with Tukey’s multiple comparisons test was used for multiple groups comparisons with matched samples. SAS 9.4 and Prism 7 were used for data analysis. A.U.: Arbitrary Units.

    Journal: Matrix biology : journal of the International Society for Matrix Biology

    Article Title: Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer

    doi: 10.1016/j.matbio.2023.11.003

    Figure Lengend Snippet: M1 and M2 marker expression is not affected by incubation with sEVs derived from healthy donors or PrCa patients. Flow cytometric analysis of monocytes isolated from healthy volunteers. ( A ) Histogram representation of the mean fluorescent intensity (MFI) of M2 polarization markers (CD163 and CD204, top panels) and M1 polarization markers (CD80 and HLA-DR, bottom panels) expressed by monocytes after incubation with PBS (−, green) or PrCa patient plasma-derived sEVs (orange) ( n = 13). The isotype control is depicted in red. ( B ) Statistical analysis of M2 marker (CD163 and CD204, top panels) and M1 marker (CD80 and HLA-DR, bottom panels) expression in monocytes after incubation with PBS (−) or PrCa patient plasma-derived sEVs ( n = 13). ( C ) Histogram representation of the MFI of M2 (top panels) and M1 (bottom panels) markers expressed by monocytes after incubation with PBS (−, green), healthy donor (Healthy d.) plasma-derived sEVs (blue), or PrCa patient plasma-derived sEVs (orange) ( n = 3). The isotype control is depicted in red. ( D ) Statistical analysis of M2 (top panels) and M1 (bottom panels) marker levels in monocytes after incubation with PBS (−), healthy donor plasma-derived sEVs or PrCa patient plasma-derived sEVs ( n = 3). ( B, D ) The results are shown in scatter graphs. Paired t -test was used for paired two group comparison; ANOVA for repeated measures with Tukey’s multiple comparisons test was used for multiple groups comparisons with matched samples. SAS 9.4 and Prism 7 were used for data analysis. A.U.: Arbitrary Units.

    Article Snippet: Flow cytometry experiments were conducted using the following mouse Abs to human: Alexa Fluor 488 conjugated CD14 (BD Biosciences, 562,689); for M2 polarization phenotyping: APC-conjugated CD163 (Miltenyi, 130–112–129 or Biolegend, 333,610), PE conjugated CD204 (BD Biosciences, 566,251); for M1 polarization phenotyping: APC conjugated CD80 (Biolegend, 305,220), PE-conjugated HLA-DR (BD Biosciences, 555,812); for isotype control: Alexa Fluor 488 conjugated IgG2b,κ isotype control (BD Biosciences, 558,716), APC conjugated REA control antibody IgG1, REAfinity TM (Miltenyi, 130–113–446) or APC conjugated IgG1,κ isotype control antibody (Biolegend, 400,120) and PE conjugated IgG1,κ isotype control (BD Biosciences, 551,436).

    Techniques: Marker, Expressing, Incubation, Derivative Assay, Isolation, Clinical Proteomics, Control, Comparison